Update on the Medical Management of Crohn’s Disease

Keyphrases

• Crohn's Disease 100%
• Treatment Strategy 100%
• Medical Management 100%
• Adverse Events 50%
• Treatment Goals 50%
• Immunosuppressive Agents 50%
• Corticosteroids 50%
• Patient Benefit 50%
• Clinical Practice 50%
• Therapeutic Agents 50%
• Patient-centered 50%
• Immunomodulator 50%
• Rapidly Evolving 50%
• Biological Agents 50%
• Gastroenterologist 50%
• Aggressive Treatment 50%
• Paradigm Change 50%
• Postoperative Setting 50%
• Control Algorithm 50%
• Anti-TNF Agents 50%
• Vedolizumab 50%
• Therapeutic Drug Monitoring 50%
• Deep Remission 50%
• Medication Efficacy 50%
• Anti-adhesion 50%
• Option Strategies 50%
• Anti-tumor Necrosis 50%

Medicine and Dentistry

• Crohn's Disease 100%
• Immunomodulating Agent 100%
• Health Care Cost 50%
• Adverse Event 50%
• High Risk Population 50%
• Therapeutic Drug Monitoring 50%
• Tumor Necrosis 50%
• TNF Inhibitor 50%
• Vedolizumab 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunomodulating Agent 100%
• Crohn's Disease 100%
• Adverse Event 50%
• Remission 50%
• Therapeutic Drug Monitoring 50%
• Tumor Necrosis Factor Inhibitor 50%
• Tumor Necrosis 50%
• Vedolizumab 50%